Inhalte und Themen
Early treatment response evaluation using FET PET compared to MRI in gliblastoma patients at first progression treated with bevacizumab plus lomustine
Einzugsgebiet
Salzburg (regional)
Leiter
Referenten
OÄ Dr. Barbara Egger - Nuklearmedizin
Interessenskonflikte
|